$304.67
0.2%
Price vs. AI Score (Last 150 days)
Data gathered: November 29
Data gathered: November 29
Data Bits
| Data Bits | Value / Change | Benchmark |
|---|---|---|
| Job Posts | 196 4.3% |
|
| Sentiment | 72 7.5% |
|
| Webpage traffic | 520,000 -5.2% |
|
| Employee Rating | 69 0% |
|
| Google Adspend | $12,959 -19.6% | N/A |
| Google Trends | 52 67.7% |
|
| Linkedin Employees | 8,532 N/A |
|
| Patents | 455 0% |
|
| 4chan Mentions | 0% |
|
| Facebook Engagement | 287 -7.4% |
|
| Facebook followers | 9,222 0.1% |
|
| Stocktwits Mentions | 1 0% |
|
| Stocktwits Subscribers | 927 0.1% |
|
| Twitter Followers | 17,335 0% |
|
| Instagram Followers | 10,417 0% |
|
| News Mentions | 0% |
|
| Reddit Mentions | 0% |
|
| Business outlook | 58 0% |
|
In the news
SPY ETF Update, 11/28/2023November 27 - TipRanks |
|
Black Friday On Wall Street: 10 S&P 500 Stocks Trading At 40%+ Discount From Analysts' ExpectationsNovember 23 - Benzinga |
|
SPY ETF Update, 11/24/2023November 23 - TipRanks |
|
SPY ETF Update, 11/23/2023���November 22 - TipRanks |
|
Global Cloning & Mutagenesis Market Size To Worth USD 12.45 Billion by 2032 | CAGR of 18.7%November 21 - GlobeNewswire |
|
 |
Implied Volatility Surging for On Bio-Rad Laboratories (BIO) Stock OptionsNovember 19 - Yahoo |
About Bio-Rad
Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the following segments: Life Sciences and Clinical Diagnostics. The Life Science segment develops, manufactures and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells and supports test systems, informatics systems, test kits and specialize in quality controls that serve clinical laboratories in the global diagnostics market.
| Price | $304.67 |
| Target Price | Sign up |
| Market Cap | $8.92B |
| Dividend Yield | 0.0171 |
| Industry | Biotechnology |
Similar companies
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | |
|---|---|---|---|---|---|
| Q3 '23 | 621M | 504M | 336M | 106M | 156M |
| Q2 '23 | 669M | 532M | 362M | -1.16B | -1.48B |
| Q1 '23 | 666M | 582M | 362M | 69M | 139M |
| Q4 '22 | 730M | 475M | 397M | 828M | 1.01B |
| Q3 '22 | 666M | 524M | 373M | -163M | -190M |
Insider Transactions
| Crowley Michael filed to sell 6,942 shares at $305.1. November 28 '23 |
| ERNST TIMOTHY S filed to sell 2,416 shares at $396.4. August 31 '23 |
| ERNST TIMOTHY S filed to sell 2,416 shares at $384.7. August 23 '23 |
| Crowley Michael filed to sell 6,040 shares at $379.4. June 16 '23 |
Read more about Bio-Rad and their earnings, price prediction, job posts, sentiment, webpage traffic, employee rating, google adspend, google trends, linkedin employees, patents, 4chan mentions, facebook engagement, facebook followers, stocktwits mentions, stocktwits subscribers, twitter followers, instagram followers, news mentions, reddit mentions, business outlook.